Impairment of serotonergic transmission by the antiparkinsonian drug L-DOPA: Mechanisms and clinical implications

1. Miguelez, C.
2. Benazzouz, A.
3. Ugedo, L.
4. De Deurwaerdère, P.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3389/FNCEL.2017.00274 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus